Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2020 | T-cell responses in pancreatic cancer

Shivan Sivakumar • 2 Nov 2020
NCRI 2020
Pancreatic Cancer

Shivan Sivakumar, MRCP, PhD, University of Oxford, Oxford, UK, discusses T-cell responses in pancreatic cancer, and how the presence of regulatory T-cells, dysfunctional and senescent T-cells restrict immune responses in pancreatic cancer cells. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:16
Entinostat with nivolumab in pancreatic ductal adenocarcinoma
Marina Baretti • 9 Apr 2024
0:40
The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer
Olatunji Alese • 8 Apr 2024
0:48
Siltuximab and spartalizumab in advanced pancreatic adenocarcinoma
Olatunji Alese • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals